Emergent Biosolutions donates thousands of NARCAN Nasal Spray units across the U.S. since 2021

Emergent Biosolutions donates thousands of NARCAN Nasal Spray units across the U.S. since 2021
Emergent donates NARCAN units

Emergent Biosolutions has announced the donation of thousands of units of NARCAN Nasal Spray throughout the U.S. since 2021.

The company referenced its ongoing commitment to social responsibility and public health in its latest ESG report, which details the scale and impact of these donations to communities nationwide. NARCAN Nasal Spray is a life-saving medicine used in cases of opioid overdose, and its wider availability is seen as a critical measure in fighting the opioid crisis. Interested parties can review Emergent Biosolutions' ESG report for more insight into these contributions.

Emergent Biosolutions has previously emphasized its continued commitment to protecting communities from health threats and saving lives, according to a recent report. The company also partnered with Substipharm Biologics to produce and support a Japanese Encephalitis vaccine in the U.S., as detailed in an earlier announcement. These initiatives form part of Emergent’s ongoing efforts in public health.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.